Bosworth, N et al., “Scintillation Proximity Assay”, Nature International Weekly Journal of Science, vol. 341, No. 6238, pp. 167-168 (Sep. 14, 1989). |
Burkett, U. et al., “Methods For The Computation Of Molecular Geometry”, Molecular Mechanics, ACS Monograph 177, pp. 59-78 (1982 American Chemical Society). |
Erice, A. et al., “Anti-Human Immunodeficiency Virus Type 1 Activity Of An Anti-CD4 Immunoconjugate Containing Pokeweed Antiviral Protein”, Antimicrobial Agents & Chemotherapy, vol. 37, No. 4, pp. 835-838 (Apr. 1993). |
Kohlstaedt, L. et al., “Crystal Structure At 3.5 Å Resolution Of HIV-1 Reverse Transcriptase Complexed With An Inhibitor”, Science, Vo. 256, pp. 1783-1790 (Jun. 26, 1992). |
Marshall, G., “Computer-Aided Drug Design”, Annual Review of Pharmacology And Toxicology, vol. 27, pp. 193-213 (1987). |
Remington's Pharmaceutical Sciences, RPS XIV, Chapter 43, pp. 764-786 (Date Unknown). |
Uckun, F. et al., “TXU (Anti-CD7)-Pokeweed Antiviral Protein As a Potent Inhibitor Of Human Immunodeficiency Virus” Antimicrobial Agents & Chemotherapy, vol. 42, No. 2, pp. 383-388 (Feb. 1998). |
Zarling, J. et al., “Inhibition of HIV Replication By Pokeweed Antiviral Protein Targeted To CD4+Cells By Monoclonal Antibodies”, Nature International Weekly Journal Of Science, vol. 347, No. 6288, pp. 92-95 (Sep. 6, 1990). |
Ambinter: Exploratory Library, Database Chemcats 'Online!, Abstract XP-002184046 (May 31, 2001). |
Ambinter: Exploratory Library, Database Chemcats 'Online!, Abstract XP-002184047 (May 31, 2001). |
Breuzard, J.A.J. et al., “Thioureas as new chiral ligands for the asymmetric hydroformylation of styrene with rhodium(I) catalysts”, J. Mol. Catal. A: Chem, 156(1-2), 223-232 (2000) Abstract. |
Drefahl et al., “Stilbenes—(XXXIX) Wittig reaction with p-halomethylbenzaldehyde”, Database Caold 'Online!, Abstract XP-002184037 (date unknown). |
Furdik et al., Synergists of pyrethrum—(VI) synthesis of endo-cis-N-substituted 7-diphenylmethylene-bicyclo[1,2,2]hept-5-ene-2,3-dicarboximides, Database Caold 'Online!, Abstract XP-002184038 (date unknown). |
Glover, Edward E., et al., “Synthesis and quaternization of heterocyclic mono-and disulfides”, J. Chem. Soc., Perkin Trans. 1 (21) 2595-9 (1973) Abstract XP-002184040. |
Iliceto, A., et al., “Thiocyanates and isothiocyanates—(III) kinetics and mechanism of benzhydryl thiocyanates isomerization”, Database Caold 'Online!, Abstract XP-002184036 (date unknown). |
Jung et al., “A study on the stability of 5,5-diamino-substituted-1,4,2-oxathiazoline derivatives”, Synth. Commun. 28(10), 1879-1884 Abstract XP-002184044 (1998). |
Mao, et al., “Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thioureaa (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus” Bioorg. Med. Chem. Lett. 9, 1593-1598, (1999). |
Nagai et al., “Bisarylthiourea fungicides”, Japan, Kokai, 6 pp. Abstract XP-002184043 (Feb. 3, 1978). |
Patel, P.R., et al., “Synthesis of 5-alkyl-3-benzyhydryl-2-arylimino-4-thiazolidones and 5-substituted benzal/cinnamal-3-benzhydryl-2-arylimino-4-thiazolidones”, J. Inst. Chem., Calcutta 48, Pt. 2, 105-8, Abstract XP-002184041 (1976). |
Sato et al., “Arylthioureas as microbicides”, Japan, Kokai, 5 pp., Abstract XP-002184042 (Dec. 18, 1976). |
Tonellato, U., et al., “Stereochemistry of ion-pair return. I. Resolution and isomerization of (-)-4-chlorobenzhydryl thiocyanate” J. Org. Chem., 34(12), 4032-4, (1969). |
Vig, R. et al., 1998 Bioorganic & Medicinal Chemistry, 6:1789-1797 Rational Design and Synthesis of Phenethyl-5-bromopyridyl Thiourea Derivatives as Potent Non-nucleoside Inhibitors of HIV Reverse Transcriptase. |
Weiner, S.J. et al., 1984, J. Am. Chem. Soc., 106, 765-784 A New Force Field for Molecular Mechanical Simulation of Nucleic Acids and Proteins. |
Zhang, et al., 1996, Antiviral Chemistry & Chemotherapy, 7(5):221-229 “Synergistic inhibition of HIV-1 reverse transcriptase and HIV-1 replication by combining trovirdine with AZT, ddl and ddC in vitro”. |
Ahgren, C., et al., 1995, Antimicrob. Agents Chemotherapy, 39, 1329-1335 The PETT Series, a New Class of Potent Nonnucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. |
Baba, M., et al., 1992, Antiviral Res., 17, 245-264 Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives. |
Balzarini, J. et al., 1992, Proc. Natl. Acad. Sci. U S A, 89, 4392-4396 2′,5′-Bis-O-(tert-butyldimethylsilyl)-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide)pyrimidine (TSAO) nucleoside analogues: Hightly selective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase. |
Bartlett. P.A. et al., 1989, Molecular Recognition in Chemical and Biological Problems, Special Pub., Royal Chem. Soc., 78, 182-196 Caveat: A Program to Facilitate the Structure-derived Design of Biologically Active Molecules. |
Bell, F. W., et al., 1995, J. Med. Chem., 38, 4929-4936 Penethylthiazolethiourea (PETT) Compounds, a New Class of HIV-1 Reverse Transcriptase Inhibitors. 1. Syntheis and Basic Structure-Activity Relationship Studies of PETT Analogs. |
Blaney, J.M. and Dixon, J.S., 1993, Perspectives in Drug Discovery and Design, 1, 301 A good ligand is hard to find: Automated docking methods. |
Bohm, H.J., 1992, J. Comput. Aided. Mol. Des., 6, 593-606 LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. |
Bohm, H.J., 1992, J. Comp. Aid. Molec. Design, 6, 61-78 The computer program LUDI: A new mehtod for the de novo design of enzyme inhibitors. |
Bohm, H. J., J. Comput. Aided. Mol. Des., 1994, 8, 243-256, 1996. The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of konwn three-dimensional structure. |
Brooks, B.R. et al., 1983, J. Comp. Chem., 4, 187-217 CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations. |
Cantrell A., et al., 1996, J. Med. Chem., 39, 4261-4274 Phenethylthiazolylthiourea (PETT) Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 2. Synthesis and Further Structure-Activity Relationship Studies of PETT Analogs. |
Chemical substance index page, Chemical Abstracts, 13th Collective Chemical Substance Index, Book 52, p. 1272 (1992-1996). |
Connolly, M. L., 1983, Science, 221, 709-713 Solvent-Accessible Surfaces of Proteins and Nucleic Acids. |
Danel, K., et al., 1996, J. Med. Chem., 39, 2427-2431 Synthesis and Potent Anti-HIV-1 Activity of Novel 6-Benzyluracil Analogues of 1-[2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine. |
Danel, K. et al., 1997 Acta Chemica Scandinavica 51, 426-430 Anti-HIV Active Napthyl Analogues of HEPT and DABO. |
Danel, K. et al., 1998, J. Med. Chem., 41, 191-198 Synthesis and Anti-HIV-1 Activity of Novel 2,3-Dihydro-7H-thiazolo[3,2-α]pyrimidin-7-ones. |
Zarling, et al., Nature, 1990, 347, 92-95. |
Das, K. et al., 1996, J. Mol. Biol., 264, 1085-1100 Crystal Structures of 8-C1 and 9-C1 TIBO Complexed with Wild-type HIV-1 RT and 8-C1 TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant Mutant. |
Davies et al., “Condensed Thiophen Ring Systems. Part XIX. Synthesis of 6,7-Dihydrothieno [3,2-c] pyridines and 4,5-Dihydrothieno [2,3-c] pyridines by Intramolecular Cyclisation of 2-(2- or 3-Thienyl)ethyl Isothiocyanate”, J.C.S. Perkin I, pp. 138-141 (1976). |
D-Cruz, O. et al., “Novel Thiourea Compounds As Dual-Function Microbicides”, Chemical Abstract, Abstract No. 133:159648d, vol. 133, No. 12, 1 page (2000). |
De Clercq, E., 1992, J. Acquired Immune Defic. Syndr. Res. Human. Retrovirus, 8, 119-134. |
Ding, J., 1995, et al., Nat. Struct. Biol., 2, 407-415 Structure of HIV-RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors. |
Gittos et al., “A New Synthesis of Isocyanates”, J.C.S. Perkin I, pp. 141-143 (1976). |
Goodsell, D.S. and Olson, A.J., 1990, Proteins: Struct. Funct. Genet., 8, 195-202 The Molecular Biology of Human Immunodeficiency Virus Type 1 Infection. |
Greene, W. C., 1991, New England Journal of Medicine, 324, 308-317 Automated Docking of Substrates to Proteins by Simulated Annealing. |
Hopkins, A. L. et al., 1996, J. Med. Chem., 39, 1589-1600 Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformational Changes Relevant to the Design of Potent Non-Nucleoside Inhibitors. |
Jones, T. A. et al., 1991, Acta Crystallogr. A., 47, 110-119 Improved Methods for Building Protein Models in Electron Denisty Maps and the Location of Errors in these Models. |
Kuntz, I.D., et al., 1995, J. Mol. Biol., 1982, 161, 269-288 A Geometric Approach to Macromolecule-Ligand Interactions. |
Luty, B. A. et al., 1995, J. Comp. Chem., 16, 454-464 A Molecular Mechanics/Grid Methods for Evaluation of Ligand-Receptor Interactions. |
Mai, A. et al., 1997, J. Med. Chem., 40, 1447-1454 Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: Novel Non-Nucleoside Reverse Transcriptase Indhibitors of the S-DABO Series. |
Mao, C. et al., “Structure-Based Design of N-[2-(1-Piperidinylethyl)]-N'-[2-(5-Bromopyridyl)]-Thiourea and N-2-(1-Piperazinylethyl)-N'-[2-(5-Bromopyridyl)]-Thiourea as Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase”, Bioorganic & Medicinal Chemistry Letters 8, pp. 2213-2218 (1998). |
Mao, C. et al., “Rational Design Of N-[2-2,5-Dimethoxyphenylethyl)]-N'-[2-(5-Bromopyridyl)]-Thiourea (HI-236) As A Potent Non-Nucleoside Inhibitor Of Drug-Resistant Human Immunodeficiency Virus”, Bioorganic & Medicinal Chemistry Letters, vol. 9, pp. 1593-1598 (1999). |
Martin, Y.C., 1992, J. Med. Chem., 35, 2145-2154 3D Database Searching in Drug Design. |
Mitsuya, H. et al., 1990, Science, 249, 1533-1544 Molecular Targets for AIDS Therapy. |
Nishibata, Y. and Itai, A., 1991, Tetrahedron, 47, 8985 Automatic Creation of Drug Candidate Structures Based on Receptor Structure. Starting Point for Artificial Lead Generation. |
Pauwel, R. et al., 1990, Nature, 343, 470-474 Potent and selective inhibitionof HIV-1 replication in vitro by a novel series of TIBO derivatives. |
Pontikis, R. et al., 1997, J. Med. Chem., 40, 1845-1854 Synthesis and Anti-HIV Activity of Novel N-1 Side Chain-Modified Analogs of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). |
Ren, J. et al., 1995, Structure, 3, 915-926 The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design. |
Romero, D. L. et al., 1993, J. Med. Chem., 36, 1505-1508 Bis)heteroaryl)piperazine (BHAP) Reverse Transcriptase Inhibitors: Structure-Activity Relationships of Novel Substituted Indole Analogues and the Identification of 1-[(5-Methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3-[(1-methylethyl)-amino]-pyridinyl]piperazine Monomethanesulfonate (U-90152S), a Second-Generation Clinical Candidate. |
Sahlberg, et al., 1998, Bioorganic & Medicinal Chemistry Letters 8, pp. 1511-1516 “Synthesis and Anti-Hiv Activities of Urea-PETT Analogs Belonging to a New Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors”. |
Sudbeck, E. A. et al., 1998, Antimicrobial Agents and Chemotherapy, 42(12), 3225-33 Structure-Based Design of Novel Dihydroalkoxybenzyloxopyrimidine Derivatives as Potent Nonnucleoside Inhibitors of the Human Immunodeficiency Virus Reverse Transcriptase. |
Tanaka, H. et al., 1991, J. Med. Chem., 34, 349-357 A New Class of HIV-1-Specific 6-Substituted Acyclouridine Derivatives: Synthesis and Anti-HIV-1 Activity of 5- or 6-Substituted Analogues of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). |
Tanaka, H. et al., “Synthesis of a Potential Photoaffinity Labeling Reagent for HIV-1 Reverse Transcriptase”, Chemical Abstracts, vol. 120, No. 17, p. 1160 (Apr. 25, 1994). |
Tantillo, C. et al., 1994, J Mol Biol, 243, 369-387 Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse Transcriptase. |
Tronchet, JMJ et al., “A QSAR Study Confirming the Heterogeneity of the HEPT Derivative Series Regarding Their Interaction with HIV Reverse Transcriptase”, Eur. J. Med. Chem., vol. 32, pp. 279-299 (1977). |
Uckun, F. et al., “N-[2-(1-Cyclohexenyl)Ethyl]-N'-[2-(5-Bromopyridyl)]-Thiourea and N'-[2-(1-Cyclohexenyl)Ethyl]-N'-[2-(5-Chloropyridyl)]-Thiourea As Potent Inhibitors of Multidrug-Resistant Human Immunodeficiency Virus-1”, Bioorganic & Medicinal Chemistry Letters, vol. 9 pp. 2721-2726, (1999). |
Vig, R. et al., “5-Alkyl-2-[(Methylthiomethyl)Thio]-6-(Benzyl)-Pyrimidin-4-(1H)-Ones as Potent Non-Nucleoside Reverse Transcriptast Inhibitors of S-DABO Series”, Bioorganic & Medicinal Chemistry Letters 8, pp. 1461-1466 (1998). |